title: PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancer.
authors.affiliation: Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany. Electronic address: thomas.wiegel@uniklinik-ulm.de.
authors.forename: Thomas
authors.initials: T
authors.lastname: Wiegel
authors.affiliation: Department of Urology, University Hospital Homburg/Saar, Homburg, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Stöckle
authors.affiliation: Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
authors.forename: Detlef
authors.initials: D
authors.lastname: Bartkowiak
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001918:Brachytherapy; D018450:Disease Progression; D006801:Humans; D008297:Male; D057240:Patient Preference; D018579:Patient Selection; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate; D057832:Watchful Waiting
chemical_list: D018931:Antineoplastic Agents, Hormonal